已收录 268921 条政策
 政策提纲
  • 暂无提纲
Development of directly compressible co-processed excipients forsolid dosage forms
[摘要] The tablets manufactured by direct compression method using co-processed excipient showed relatively better disintegration time and in vitro drug release, with omission of number of laborious steps as compared to tablets manufactured by conventional wet granulation method. Melt granulation technique is a potential alternative for the development of directly compressible adjuvants. Lactose and mannitol blend (1:1, 1:2, 2:1, 1:3, 3:1; 90, 80 or 70 %) along with meltable binders PVP K – 30 and PEG 4000 (1:9, 1:1 or 9:1) were used in the formulation. The effect of addition of co-processed excipient in a formulation containing poorly compressible drug (paracetamol) was also studied. The micromeritic studies and bulk powder properties of the co-processed agglomerates were studied. It was observed that co-processed agglomerates exhibited much better flow properties as compared to individual excipients. The optimized formulation shows that the tensile strength was found to be inversely related with the percentage of acetaminophen. It might be due to the poor compressibility and elastic recovery of acetaminophen. Lower value of disintegration time may be attributed to decreased tensile strength. No capping and lamination of tablet was observed as usually associated with acetaminophen compression.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文